Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy.

Clin Nurse Spec

Author Affiliation: Nurse Scientist & Faculty, Premier Health - Miami Valley Hospital, Dayton, Ohio 1 Wyoming Street NW 4242 Dayton, OH 45409.

Published: April 2024

Download full-text PDF

Source
http://dx.doi.org/10.1097/NUR.0000000000000821DOI Listing

Publication Analysis

Top Keywords

mavacamten camzyos
4
camzyos first-in-class
4
first-in-class small-molecule
4
small-molecule myosin
4
myosin inhibitor
4
inhibitor treatment
4
treatment obstructive
4
obstructive hypertrophic
4
hypertrophic cardiomyopathy
4
mavacamten
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!